Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia (Q48832403)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 1994

Language	Label	Description	Also known as
English	Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia	scientific article published in October 1994

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

hypercholesterolemia

0 references

author name string

Kostis JB

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

Rosen RC

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

Wilson AC

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

publication date

1 October 1994

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

34

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

10

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

989-996

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Central nervous system effects of beta-adrenergic-blocking drugs: the role of ancillary properties

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Beta-blockers and central nervous system side effects

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Effects of lovastatin and pravastatin on sleep efficiency and sleep stages

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Depressive symptoms in hypercholesterolaemic patients treated with pravastatin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Depressive symptoms and cholesterol-lowering drugs

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1994.TB01971.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1994.TB01971.X

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/7836550

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48832403&oldid=2211832612"